Previous studies reported that overexpression of JAK2 in breast cancer promotes cancer cell survival and growth by modulating cell proliferation and apoptosis, partly through the upregulation of cyclin D1 and Bcl-2 family members, such as Bcl-xL and Bcl-2 [33,34,35,36]. Here, BCL2L1 is linked to breast carcinoma.